---
title: Assoc Prof Mark Chan
permalink: /assoc-prof-mark-chan/
variant: tiptap
description: ""
image: /images/ASPIRE Network /Mark_Chan.png
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 30%;" height="auto" width="100%" alt="" src="/images/ASPIRE Network /Mark_Chan.jpg">
</div>
<h4>Associate Professor Mark Chan</h4>
<p>Dr Mark Chan, MBBS, PhD, is an Associate Professor with tenure at the
Department of Medicine, Yong Loo Lin School of Medicine, National University
of Singapore and Senior Consultant and practising interventional cardiologist
at National University Heart Centre, Singapore.</p>
<p>In 2019, he received the National Medical Research Council Clinician Scientist
Senior Investigator Award. He is deputy director of the Cardiovascular
Disease Translational Research Programme, NUS, and supervises translational
research and clinical trials of acute myocardial infarction at the Cardiovascular
Research Institute, NUS. He leads both basic science and clinical research
team at the Cardiovascular Research Institute and National University Heart
Centre, Singapore.</p>
<p>Among other federally-funded and industry-supported projects, A/Prof Chan
is the overall PI of the national Acute Myocardial Infarction: allied Health-Oriented,
Patient-centred and technology-Enabled (AMI-HOPE) programme with National
University Health System, Singhealth and National Healthcare Group colleagues.
He is also the overall PI of the three-country randomised controlled trial
of an anti-inflammatory small-molecule inhibitor to treat atherosclerosis
in patients with AMI (PASSIvation of Vulnerable plaques with AZD5718 in
acuTE coronary syndrome â€“ the PASSIVATE trial).</p>
<p>A/Prof Chan has published more than 260 peer-reviewed papers and has published
in JAMA, Circulation, JAMA Cardiology, European Heart Journal, Nature Communications,
JACC Cardiovascular Interventions, Journal of Thrombosis and Haemostasis
and JACC Cardiovascular Interventions.</p>
<p>&nbsp;</p>